← Back to Search

Diagnostic Device

ANNE Sleep for Sleep Apnea

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 nights
Awards & highlights
No Placebo-Only Group

Summary

This trial tests ANNE, a new tool for diagnosing sleep problems, in people with moderate to severe OSA, especially those aged 65 and older. It aims to see if ANNE works as well as current methods and if it is easier to use.

Eligible Conditions
  • Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 nights
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 nights for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ANNE SleepExperimental Treatment1 Intervention
After consent, subjects will wear the ANNE Sleep system with HST for 1 night and 3 nights with ANNE sleep system alone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ANNE Sleep
2022
N/A
~330

Find a Location

Who is running the clinical trial?

Sibel HealthUNKNOWN
1 Previous Clinical Trials
287 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,640 Previous Clinical Trials
957,534 Total Patients Enrolled
2 Trials studying Sleep Apnea
174 Patients Enrolled for Sleep Apnea
Sibel Health Inc.Industry Sponsor
4 Previous Clinical Trials
339 Total Patients Enrolled
~10 spots leftby Nov 2025